Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 49% ± 12% | |
lung | 19 studies | 43% ± 14% | |
intestine | 13 studies | 30% ± 11% | |
eye | 11 studies | 44% ± 17% | |
kidney | 9 studies | 47% ± 12% | |
brain | 9 studies | 33% ± 15% | |
bone marrow | 6 studies | 38% ± 14% | |
liver | 6 studies | 42% ± 15% | |
lymph node | 6 studies | 53% ± 13% | |
pancreas | 5 studies | 47% ± 23% | |
uterus | 5 studies | 44% ± 21% | |
placenta | 4 studies | 57% ± 17% | |
prostate | 4 studies | 27% ± 6% | |
breast | 4 studies | 34% ± 5% | |
ovary | 3 studies | 20% ± 5% | |
heart | 3 studies | 25% ± 7% | |
adipose | 3 studies | 29% ± 9% | |
adrenal gland | 3 studies | 47% ± 12% | |
esophagus | 3 studies | 44% ± 20% | |
skin | 3 studies | 24% ± 7% | |
thymus | 3 studies | 62% ± 27% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 21454.96 | 1445 / 1445 | 100% | 257.25 | 183 / 183 |
lung | 100% | 17842.81 | 576 / 578 | 100% | 459.25 | 1151 / 1155 |
ovary | 100% | 10136.95 | 180 / 180 | 99% | 287.59 | 427 / 430 |
stomach | 100% | 11013.95 | 358 / 359 | 99% | 301.37 | 283 / 286 |
intestine | 100% | 13841.34 | 966 / 966 | 99% | 374.51 | 520 / 527 |
breast | 100% | 14618.12 | 459 / 459 | 99% | 309.22 | 1103 / 1118 |
uterus | 100% | 10386.85 | 170 / 170 | 98% | 372.30 | 450 / 459 |
kidney | 100% | 21152.22 | 89 / 89 | 98% | 500.46 | 883 / 901 |
skin | 100% | 25408.22 | 1808 / 1809 | 98% | 410.13 | 462 / 472 |
bladder | 100% | 14871.43 | 21 / 21 | 96% | 360.48 | 486 / 504 |
brain | 97% | 13640.58 | 2568 / 2642 | 99% | 258.64 | 699 / 705 |
thymus | 100% | 13093.08 | 651 / 653 | 94% | 162.31 | 571 / 605 |
prostate | 100% | 11145.08 | 244 / 245 | 94% | 161.01 | 473 / 502 |
adrenal gland | 100% | 21499.13 | 258 / 258 | 89% | 276.91 | 205 / 230 |
pancreas | 84% | 4990.14 | 274 / 328 | 97% | 260.06 | 173 / 178 |
liver | 92% | 10240.22 | 207 / 226 | 88% | 158.16 | 356 / 406 |
adipose | 100% | 17369.73 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 323.92 | 29 / 29 |
muscle | 100% | 26139.54 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 17817.57 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 417.49 | 45 / 45 |
blood vessel | 100% | 16596.16 | 1333 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 54825.49 | 926 / 929 | 0% | 0 | 0 / 0 |
heart | 96% | 21110.65 | 824 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 167.03 | 70 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016310 | Biological process | phosphorylation |
GO_0061621 | Biological process | canonical glycolysis |
GO_0006094 | Biological process | gluconeogenesis |
GO_0006096 | Biological process | glycolytic process |
GO_0031639 | Biological process | plasminogen activation |
GO_0030855 | Biological process | epithelial cell differentiation |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0016525 | Biological process | negative regulation of angiogenesis |
GO_0045121 | Cellular component | membrane raft |
GO_0005615 | Cellular component | extracellular space |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0016020 | Cellular component | membrane |
GO_0043531 | Molecular function | ADP binding |
GO_0004618 | Molecular function | phosphoglycerate kinase activity |
GO_0047134 | Molecular function | protein-disulfide reductase (NAD(P)H) activity |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | PGK1 |
Protein name | Phosphoglycerate kinase 1 (EC 2.7.2.3) (Cell migration-inducing gene 10 protein) (Primer recognition protein 2) (PRP 2) |
Synonyms | PGKA MIG10 OK/SW-cl.110 |
Description | FUNCTION: Catalyzes one of the two ATP producing reactions in the glycolytic pathway via the reversible conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate . In addition to its role as a glycolytic enzyme, it seems that PGK-1 acts as a polymerase alpha cofactor protein (primer recognition protein) . May play a role in sperm motility . . |
Accessions | P00558 ENST00000644362.1 [P00558-2] ENST00000373316.5 [P00558-1] |